SCHEMBL6973943

SCHEMBL6973943

COC(=O)c1ccc(C2(C)OCC3(CO2)c2ccccc2-c2ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.44
RAB9A P51151 3/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TSHR P16473 1/20 0.41
MDM2 Q00987 1/20 0.41
MAPT P10636 5/20 0.40
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 2/20 0.38
ITGA4 P13612 1/20 0.38
CDC25B P30305 2/20 0.38
PTPRC P08575 1/20 0.38
PTPRF P10586 1/20 0.38
PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13041368 0.77 RAB9A (0.49) RAB9ANPC1SMN1; SMN2TSHRMAPT
SCHEMBL6982305 0.75 ALDH1A1 (0.43) PDK2MAPTL3MBTL1ALDH1A1ITGA4
SCHEMBL23883482 0.73 RAB9A (0.54) RAB9ANPC1SMN1; SMN2TSHRMAPT
SCHEMBL6968252 0.72 MEN1 (0.42) SMN1; SMN2MAPTL3MBTL1ALDH1A1ITGA4
SCHEMBL25364240 0.71 TSHR (0.55) RAB9ANPC1SMN1; SMN2TSHRMAPT
SCHEMBL28831179 0.70 PDK2 (0.48) PDK2RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL6982212 0.70 THRB (0.46) PDK2MAPTRARBRARGL3MBTL1
SCHEMBL6971971 0.69 NPC1 (0.44) PDK2RAB9ANPC1MAPTALDH1A1
SCHEMBL31522049 0.68 TSHR (0.60) RAB9ANPC1SMN1; SMN2TSHRMAPT
SCHEMBL6981621 0.68 APEX1 (0.42) TSHRMAPTALDH1A1ITGA4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed